维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="TOTANI Y"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A phaseⅡstudy of S-1 monotherapy as second-line treatment for advanced non-smal cell lung cancer显示文摘	Totani Y Saito Y Hayash M	2009	Cancer chemotherapy pharmacel2009，，18：	1
2	A phase 11 study of S - 1 monotherapy as sec- ond- line treatment for advanced non - small cell lung cancer 显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Che- mother Pharmacol2009，18，6：	1
3	A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother Phar- macol2009，64，6：	1
4	A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer 显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother Phar- maeol2009，64，6：	1
5	A case of lymphocytic interstitial pneumonia with Sjogren's syndrome and systemic lupus erythematosus in which human herpesvirus-6 infection was the suspected pathogen 显示文摘	Demura Y Ameshima S	2001	Nihon Kokyuki Gakkai Zasshi2001，39，10：	1
6	A phase Ⅱ study of S -1 monotherapy as second-line treatment for advanced non-small cell lung cancer 显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother Pharmacol2009，64，6：	1
7	A phase II study of S-1 monotherapy as second -line treatment for advanced non-small cell lung Cancer显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother Pharmacol2009，64，6：	1
8	A phase Ⅱ study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother Pharmacol Lung Cancer2009，64，6：	1
9	A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother Pharmaco12009，18，6：	1
10	A phase II study of S-1 monotherapy as second-line treatment for advanc, ed non-small eel lung cancer 显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother Pharmacol2009，64，6：	1
11	A phase II study of S-1 mono therapyassecond-linetreatmentforadvanced)non-smallcelllungcancer显示文摘	Totani Y Saito Y Hayashi M	2009	CancerChemother Pharmacol2009，64，6：	1
12	Chemical approaches toward understanding glycanmediated protein quality control显示文摘	Takeda Y Totani K Matsuo I	2009	Current Opinion in Chemical Biology2009，13，56：	1
13	A phase II study of S- 1 monotherapy as second-line treatment for advanced non-small cell lung cancer显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother Phar- macol2009，64，6：	1
14	A phase II study of S-lmonotherapy as second line treatment for advanced non-small celllung cancer显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother Phallnacol2009，64，6：	1
15	A phase ]I study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother Pharmacol2009，64，6：	1
16	A phase Ⅱ study of S- 1 monotherapyas second-line treatment for advanced non-small cell lung cancer显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother PharmacoI2009，，64：	1
17	Extraction of phospholipids from plant oils and colorimetric determination of total phosphorus显示文摘	TOTANI Y PRETORIUS H DU PLESSIS L	1982	Journal of the American Oil Chemists’Society1982，59，4：	1
18	Silicosis characterized by increasing serum CA19-9 in parallel with progression of lung fi- brosis 显示文摘	Totani Y Demura Y Ameshima S	2000	Nihon Kokyuki Gakkai Zasshi2000，38，2：	1
19	Clinical characterization of CA19-9 in patients with interstitial pneumonia showing pathological nonspeei ficinterstitial pneumonia pattern显示文摘	Totani Y Saito Y Miyachi H	2005	Nihon Kokyuki Gak- kai Zasshi2005，43，2：	1
20	A phase II study of S - 1monotherapy as second - line treatment for advanced non - small celllung cancer 显示文摘	Totani Y Saito Y Hayashi M	2009	Cancer Chemother Pharmacol2009，64，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示